Beyond pharmacology in heart attacks: Coronary stents and stem cells

Cheuk Kit Wong, Neal S. Kleiman, Harvey D. White

Research output: Contribution to journalReview articlepeer-review


The past two decades have been tremendously exciting for clinicians managing patients suffering myocardial infarction, as we defined our understanding of the proximate cause of the thrombotic occlusion of the infarct-related artery, triggered mostly by a ruptured or fissured coronary plaque, with downstream embolism of thrombotic material and resultant myocardial necrosis. This article summarizes developments in non pharmacological therapy with percutaneous coronary artery stenting of the culprit occlusion, and newer approaches in reparative cardiology via stemcell implantation in the infarcted zone.

Original languageEnglish (US)
Pages (from-to)19-23
Number of pages5
JournalHeart and Metabolism
Issue number36
StatePublished - 2007


  • Myocardial infarction
  • Stem cells
  • Stents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Beyond pharmacology in heart attacks: Coronary stents and stem cells'. Together they form a unique fingerprint.

Cite this